Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ixoten

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Introduction A 49-year-old man, former top-athlete had "whoops" with residual tumour and re-resection of a pleomorphic… Expand
Is this relevant?
Review
2007
Review
2007
The oxazaphosphorines including cyclophosphamide (CPA, Cytoxan, or Neosar), ifosfamide (IFO, Ifex) and trofosfamide (Ixoten… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
SummaryUrotoxic side effects, especially hemorrhagic cystitis, have so far been a limiting factor in the therapeutic use of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2004
2004
Trofosfamide (Ixoten; Baxter Oncology, Germany) is an alkylating agent that, as with other oxazaphosphorine derivatives, has to… Expand
Is this relevant?
1997
1997
GOALS OF WORK There is a need for an effective and nontoxic chemotherapy for palliative indication in non-Hodgkin's lymphoma (NHL… Expand
Is this relevant?
1983
1983
As a result of traumata, cancer or chemical poisoning the level of acute-phase proteins released by the liver undergoes a… Expand
  • figure 2
Is this relevant?
1980
1979
1979
Clinical experience with Ixoten (trofosfamide), a derivative of cyclophosphamide, is reported in 29 patients with malignant… Expand
Is this relevant?
1979
1979
In an open multicenter phase III trial, prophylaxis of the urinary tract with sodium 2-mercaptoethanesulfonate (Mesnum) was… Expand
Is this relevant?
1978
1978
The efficacy of trofosfamide (Ixoten; Noristan), a derivative of cyclophosphamide, was investigated in 76 patients. Those with… Expand
Is this relevant?